Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study.

Autor: Uddin MF; Department of Endocrinology and Metabolism, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, 1000, Bangladesh., Khan MA; Department of Endocrinology and Metabolism, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, 1000, Bangladesh., Selim S; Department of Endocrinology and Metabolism, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, 1000, Bangladesh., Sultana N; Department of Endocrinology and Metabolism, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, 1000, Bangladesh., Sayem MA; Popular Diagnostic Centre Ltd. Dhanmondi, Dhaka, 1205, Bangladesh., Iftekhar MM; Department of Diabetes and Endocrinology, BIRDEM General Hospital, Dhaka, 1000, Bangladesh., Habib MB; Department of Medicine, Uttara Adhunik Medical College & Hospital, Dhaka, 1230, Bangladesh., Akter N; Department of Endocrinology and Metabolism, MARKS Medical College & Hospital, Dhaka, 1206, Bangladesh., Khan S; Department of Endocrinology, Enam Medical College & Hospital, Dhaka, 1340, Bangladesh.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2024 Feb; Vol. 13 (2), pp. e230132. Date of Electronic Publication: 2024 Jan 31.